Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3

Human Molecular Genetics, Oct 2001

Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant polyglutamine disorder presenting with progressive cerebellar ataxia and blindness. The molecular mechanisms underlying the selective neuronal death typical of SCA7 are unknown. We have established SCA7 cell culture models in HEK293 and SH-SY5Y cells, in order to analyse the effects of overexpression of the mutant ataxin-7 protein. The cells readily formed anti-ataxin-7 positive, fibrillar inclusions and small, nuclear electron dense structures. We have compared the inclusions in cells expressing mutant ataxin-7 and in human SCA7 brain tissue. There were consistent signs of ongoing abnormal protein folding, including the recruitment of heat-shock proteins and proteasome subunits. Occasionally, sequestered transcription factors were found. Activated caspase-3 was recruited into the inclusions in both the cell models and human SCA7 brain and its expression was upregulated in cortical neurones, suggesting that it may play a role in the disease process. Finally, on the ultrastructural level, there were signs of autophagy and nuclear indentations, indicative of a major stress response in cells expressing mutant ataxin-7.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://hmg.oxfordjournals.org/content/10/22/2569.full.pdf

Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3

C. Zander 1 2 J. Takahashi 0 1 5 K. H. El Hachimi 1 4 H. Fujigasaki 1 2 V. Albanese 1 A. S. Lebre 1 2 G. Stevanin 1 2 C. Duyckaerts 0 1 A. Brice 1 2 3 0 Laboratoire de Neuropathologie 1 Unit, Department of Molecular Medicine, Karolinska Institute , Stockholm , Sweden 2 INSERM U289, Hopital de la Salpetriere , 47 boulevard de l'Hopital, 75651 Paris, Cedex 13 , France 3 Departement de Genetique, Cytogenetique et Embryologie, Hopital de la Salpetriere , 75651 Paris 4 INSERM U106 and Ecole Pratique des Hautes Etudes 5 Division of Neuropathology, The Jikei University School of Medicine , Tokyo , Japan Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant polyglutamine disorder presenting with progressive cerebellar ataxia and blindness. The molecular mechanisms underlying the selective neuronal death typical of SCA7 are unknown. We have established SCA7 cell culture models in HEK293 and SH-SY5Y cells, in order to analyse the effects of overexpression of the mutant ataxin-7 protein. The cells readily formed anti-ataxin-7 positive, fibrillar inclusions and small, nuclear electron dense structures. We have compared the inclusions in cells expressing mutant ataxin-7 and in human SCA7 brain tissue. There were consistent signs of ongoing abnormal protein folding, including the recruitment of heat-shock proteins and proteasome subunits. Occasionally, sequestered transcription factors were found. Activated caspase-3 was recruited into the inclusions in both the cell models and human SCA7 brain and its expression was upregulated in cortical neurones, suggesting that it may play a role in the disease process. Finally, on the ultrastructural level, there were signs of autophagy and nuclear indentations, indicative of a major stress response in cells expressing mutant ataxin-7. - Spinocerebellar ataxia type 7 (SCA7) is one of nine known polyglutamine disorders (15). The group also includes Huntingtons disease (HD), spinal and bulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA), SCA1-3, 6 and SCA17/TBP disease. SCA7 is an autosomal dominant neurodegenerative disorder, characterized by cerebellar ataxia and visual loss. Pathologically, there is progressive macular degeneration associated with predominant neuronal loss in the cerebellar cortex, the brain stem and the inferior olivary complex. The underlying genetic mutation is an abnormal expansion of a polymorphic CAG repeat (36300 units in patients, 435 units in controls) in the 5 region of the SCA7 gene. The propensity of the repeat to expand in SCA7 results in striking anticipation (6). The SCA7 gene encodes a widely expressed 892 amino acid protein, ataxin-7, of unknown function (712). The protein has a functional nuclear localization signal (NLS) (13), but endogenous ataxin-7 is found both in the cytoplasm and in the nucleus in neurones. In COS1 cells overexpressed ataxin-7 is associated with the nuclear matrix and nucleolus (13). The protein carries a motif related to the phosphate-binding site of arrestins (14) and several SH3-binding domains through which it interacts with a Cbl associated protein (15). Polyglutamine containing proteins have an inherent ability to aggregate when the length of the polyglutamine tract exceeds 3540 glutamines, the threshold above which most of the diseases develop (16). The hallmark of a polyglutamine disease is the presence of ubiquitinated aggregates, neuronal intranuclear inclusions (NIIs), which have been found in human brain, transgenic mice- and cell-models (17). Several groups of proteins, such as elements of the ubiquitinproteasome system and transcription factors, are sequestered in the NIIs. However, whether the inclusions are only a marker of the disease or part of the disease process is a matter of debate (1820). Some studies in transfected cell cultures and transgenic mice have suggested that critical nuclear processes might be perturbed by the polyglutamine expansion and that altered gene transcription may be a major cause of cellular dysfunction (2123). Why this occurs in only selective neuronal populations, is not known, but it has been hypothesized that the polyglutamine expansions trigger a toxic gain of function, eventually through altered interactions with selectively expressed proteins. The molecular pathways leading to neuronal dysfunction and subsequent death in SCA7 are poorly understood. In an attempt to approach the role of the inclusions and associated abnormalities in SCA7 pathogenesis, we have characterized the inclusions and morphological alterations in HEK293 and SH-SY5Y cells expressing mutant ataxin-7 and the inclusions in human SCA7 cases. Several heat-shock proteins, subunits of the proteasome, transcription factors and activated caspase-3 were detected in a subset of inclusions, and overall caspase-3 immunoreactivity was enhanced in post-mortem SCA7 brain tissue compared to normal brain. There were also ultrastructural signs of autophagy and nuclear indentations, (...truncated)


This is a preview of a remote PDF: https://hmg.oxfordjournals.org/content/10/22/2569.full.pdf

C. Zander, J. Takahashi, K. H. El Hachimi, H. Fujigasaki, V. Albanese, A. S. Lebre, G. Stevanin, C. Duyckaerts, A. Brice. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3, Human Molecular Genetics, 2001, pp. 2569-2579, 10/22, DOI: 10.1093/hmg/10.22.2569